Survey with companies and authors (Gene delivery system Extension Survey)
Requirement
The client is engaged in manufacturing medical products and reagents that find applications in diagnostics. The client wants TBRC to conduct surveys on gene delivery technology for human T-Cells.–
Survey-1:
Gene Delivery Systems That Are Currently In Use
Make Of Electroporator?, Transfection Reagent Being Used
Viral Vector Currently In Use
Associated Risks For Human T-cell Gene Therapy
Survey-2:
Contacting industry experts who chose electroporation for gene delivery in the earlier study
Survey-1:
Gene Delivery Systems That Are Currently In Use
Make Of Electroporator?, Transfection Reagent Being Used
Viral Vector Currently In Use
Associated Risks For Human T-cell Gene Therapy
Survey-2:
Contacting industry experts who chose electroporation for gene delivery in the earlier study
Solution
We delivered a custom report to the client covering the following –
Survey-1:
Insights from academic researchers on the following:
Most popular gene delivery technique currently in use
Make of electroporator currently in use
Make of transfection reagent widely used?
Type of virus vector widely used?
Associated risks for human t-cell gene therapy
Other conclusions and recommendations
Survey-2:
Actionable insights will be provided for survey-2 based on the agreed questionnaire with the client
Survey-1:
Insights from academic researchers on the following:
Most popular gene delivery technique currently in use
Make of electroporator currently in use
Make of transfection reagent widely used?
Type of virus vector widely used?
Associated risks for human t-cell gene therapy
Other conclusions and recommendations
Survey-2:
Actionable insights will be provided for survey-2 based on the agreed questionnaire with the client
Methodology
We also collected insights through primary interviews. We contacted the following respondents:
For Survey-1:
We have contacted around 20 researchers who have hands-on experience in electroporation technic for Gene delivery.
For Survey-2:
We have contacted around 8-10 companies who opted for electroporation as their primary method for Gene delivery.
For Survey-1:
We have contacted around 20 researchers who have hands-on experience in electroporation technic for Gene delivery.
For Survey-2:
We have contacted around 8-10 companies who opted for electroporation as their primary method for Gene delivery.
Client Benefits and Feedback
The client was satisfied with the findings of our study.